🔥🐔 BizChicken 🐔🔥
Companies Similar to PureTech Health plc
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
CytomX Therapeutics, Inc.
Probody technology platform
Cytom X Therapeutics, Inc. is an oncology-focused biopharmaceutical company that develops antibody therapeutics based on its Probody technology platform for treating cancer. Its product candidates include CX-2009, CX-2029, BMS-986249, BMS-986288, CX-2043, and CX-904, targeting various cancers and currently in clinical trials.
Symbol: CTMX
Recent Price: $1.02
Industry: Biotechnology
CEO: Dr. Sean A. McCarthy DPHIL
Sector: Healthcare
Employees: 120
Address: 151 Oyster Point Boulevard, South San Francisco, CA 94080
Phone: 650 515 3185
Last updated: 2024-12-31
Kiromic BioPharma, Inc.
ALEXIS-ISO-1, ALEXIS-PRO-1
Kiromic Bio Pharma, Inc. is an artificial intelligence-driven allogeneic cell therapy company that develops multi-indication T cell therapies, leveraging the Gamma Delta T cell to target solid tumors. Key products include ALEXIS-ISO-1 and ALEXIS-PRO-1.
Symbol: KRBP
Recent Price: $0.93
Industry: Biotechnology
CEO: Mr. Pietro Bersani CPA, J.D.
Sector: Healthcare
Employees: 35
Address: 7707 Fannin, Houston, TX 77054
Phone: 832 968 4888
Leadership
- Pietro Bersani, CPA, Director
- Leonardo Mirandola, PhD, Chief Scientific Officer/Interim COO
- Scott Dahlbeck, MD, PharmD, Chief of Staff
- Brian Hungerford, Chief Financial Officer
- Michael Nagel, Chairperson
- Michael Catlin, Independent Director
- Pam Misajon, Independent Director
Last updated: 2024-12-31
Prelude Therapeutics Incorporated
PRT543
Prelude Therapeutics Incorporated is a clinical-stage precision oncology company focusing on novel precision cancer medicines, including products like PRT543, PRT811, PRT1419, PRT2527, and others at various stages of development or trials.
About | Leadership | Directors | About | Contact | Contact | Careers | Careers | Jobs | About | About
Symbol: PRLD
Recent Price: $1.21
Industry: Biotechnology
CEO: Dr. Krishna Vaddi D.V.M., Ph.D.
Sector: Healthcare
Employees: 128
Address: 200 Powder Mill Road, Wilmington, DE 19803
Phone: 302 467 1280
Leadership
- Kris Vaddi, Ph.D., Chief Executive Officer
- Jane Huang, M.D., President and Chief Medical Officer
- Bryant Lim, Chief Legal Officer, Corporate Secretary & Interim Chief Financial Officer
- Andrew Combs, Ph.D., Chief Chemistry Officer
- Peggy Scherle, Ph.D., Chief Scientific Officer
- Michele Porreca, M.B.A., Chief People Officer
- Sean Brusky, M.B.A., Chief Business Officer
- Naveen Babbar, Ph.D., Senior Vice President, Translation Medicine
- Aimee Crombie, Ph.D., SVP & Head of Strategic Planning & Operations
- Robert Doody, Senior Vice President, Investor Relations
- Wan-Jen Hong, M.D., Senior Vice President, Clinical Development
- Bill Novotny, M.D., Senior Vice President, Clinical Development
- Madhu Pudipeddi, Ph.D., Senior Vice President, Technical Operations
- Paul A. Friedman, M.D., Chair
- David Bonita, M.D., Director
- Julian C. Baker, Director
- Mardi C. Dier, Director
- Victor Sandor, M.D., Director
- Martin Babler, Director
Last updated: 2024-12-31
Tonix Pharmaceuticals Holding Corp.
TNX-1500, TNX-2900, TNX-801, TNX-1840, TNX-1850, TNX-3500
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company that focuses on developing therapies for immunology, rare diseases, infectious diseases, and central nervous system disorders. Key products include TNX-1500 for organ transplant and autoimmune diseases, TNX-2900 for Prader-Willi syndrome, and TNX-801 for smallpox prevention.
Symbol: TNXP
Recent Price: $0.36
Industry: Biotechnology
CEO: Dr. Seth Lederman M.D.
Sector: Healthcare
Employees: 103
Address: 26 Main Street, Chatham, NJ 07928
Phone: 862 799 8599
Last updated: 2024-12-31
Black Diamond Therapeutics, Inc.
BDTX-189, BDTX-1535, BDTX-4933
Black Diamond Therapeutics, Inc. is a biotechnology company that discovers, develops, and commercializes medicines for patients with genetically defined tumors. The company focuses on creating irreversible small molecule inhibitors to target specific oncogenic proteins.
Symbol: BDTX
Recent Price: $2.15
Industry: Biotechnology
CEO: Dr. Mark A. Velleca M.D., Ph.D.
Sector: Healthcare
Employees: 54
Address: One Main Street, Cambridge, MA 02142
Phone: 617 252 0848
Leadership
- Ali Behbahani, M.D., Co-Head of Healthcare, NEA
- Shannon Campbell, Executive Vice President and Chief Commercial Officer, Merus
- Kapil Dhingra, M.D., Former Head, Roche Oncology Development
- Samarth (Sam) Kulkarni, Ph.D., CEO, CRISPR Therapeutics AG
- Garry E. Menzel, Ph.D., Operating Partner, GHO Capital Partners LLP
- Prakash Raman, Ph.D., CEO of InduPro, Inc.
- Mark A. Velleca, M.D., Ph.D., CEO and Board Chair
Last updated: 2024-12-31
Compass Therapeutics, Inc.
CTX-009, CTX-471, CTX-8371
Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing antibody-based therapeutics to treat various human diseases. Their clinical stage products include investigational bispecific antibodies like CTX-009 and monoclonal antibodies such as CTX-471.
Symbol: CMPX
Recent Price: $1.48
Industry: Biotechnology
CEO: Dr. Thomas J. Schuetz M.D., Ph.D.
Sector: Healthcare
Employees: 32
Address: 80 Guest Street, Boston, MA 02135
Phone: 617 500 8099
Last updated: 2024-12-31
Inhibikase Therapeutics, Inc.
Ik T-148009
Inhibikase Therapeutics, Inc. is a clinical stage pharmaceutical company focused on developing therapeutics for Parkinson's Disease and related disorders. Their product pipeline includes treatments for neurological and cancer-related conditions.
About | Leadership | Directors | About | About | About | Contact | Careers | About | About | About | About
Symbol: IKT
Recent Price: $3.24
Industry: Biotechnology
CEO: Dr. Milton H. Werner Ph.D.
Sector: Healthcare
Employees: 8
Address: 3350 Riverwood Parkway SE, Atlanta, GA 30339
Phone: 678 392 3419
Leadership
- Milton H. Werner, Ph.D., President and CEO
- C. Warren Olanow MD, FRCPC, FRCP (Hon.), Medical Consultant and CEO of Clintrex Research Corporation
- Garth Lees-Rolfe, CPA, Chief Financial Officer
- Dan Williams, Controller
- Terence Kelly, Ph.D., Medicinal Chemistry Consultant
- Surendra Singh, Ph.D., Chemistry and Manufacturing Controls
- Merrill M. Kraines, Partner, McDermott, Will & Emery, Outside General Counsel
- Roberto Bellini, Managing Partner at BSQUARED Capital
- Dennis Berman, Serial Entrepreneur
- David Canner, Ph.D., Partner at Soleus Capital
- Roy Freeman, M.D., Professor of Neurology at the Harvard Medical School, Director of the Center for Autonomic and Peripheral Nerve Disorders, Beth Israel Deaconess Medical Center
- Arvind Kush, Chief Financial Officer and Chief Business Officer of Candid Therapeutics
- Amit Munshi, Chief Executive Officer of Orna Therapeutics
Last updated: 2024-12-31
Karyopharm Therapeutics Inc.
XPOVIO
Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company focused on discovering, developing, and commercializing drugs targeting nuclear export for the treatment of cancer and other diseases, with a flagship product named XPOVIO.
Symbol: KPTI
Recent Price: $0.70
Industry: Biotechnology
CEO: Mr. Richard A. Paulson M.B.A.
Sector: Healthcare
Employees: 325
Address: 85 Wells Avenue, Newton, MA 02459
Phone: 617 658 0600
Leadership
- Richard Paulson, President and Chief Executive Officer
- James Accumanno, Chief Compliance Officer
- Brian Austad, Senior Vice President, Pharmaceutical Sciences
- Sohanya Cheng, Chief Commercial Officer and Head of Business Development
- Lisa DiPaolo, Chief Human Resources Officer
- Mike Mano, Senior Vice President and General Counsel
- Michael Mason, Chief Financial Officer
- Stuart Poulton, Chief Development Officer
- Reshma Rangwala, Chief Medical Officer & Head of Research
- Amama Sadiq, Senior Vice President, Global Medical and Scientific Affairs
- Elhan Webb, Senior Vice President, Investor Relations
- Garen Bohlin, Director
- Barry E. Greene, Lead Director
- Mansoor Raza Mirza, MD, Director
- Richard Paulson, MBA, President and Chief Executive Officer
- Christy J. Oliger, Director
- Deepa R. Pakianathan, PhD, Director
- Chen Schor, Director
- Zhen Su, MD, MBA, Director
Last updated: 2024-12-31
Keros Therapeutics, Inc.
KER-050
Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for hematological and musculoskeletal disorders. Their lead product candidate, KER-050, targets cytopenias, including anemia and thrombocytopenia.
About | Management | Directors | Contact | About | Contact | Careers | Benefits | Careers | About | Benefits | About | Careers | Jobs | Careers | Careers | Careers
Symbol: KROS
Recent Price: $15.64
Industry: Biotechnology
CEO: Dr. Jasbir S. Seehra Ph.D.
Sector: Healthcare
Employees: 149
Address: 99 Hayden Avenue, Lexington, MA 02421
Phone: 617 314 6297
Leadership
- Jasbir Seehra, Ph.D., Board Member
- Keith Regnante, M.B.A., Chief Financial Officer
- Christopher Rovaldi, President, Chief Operating Officer
- Esther Cho, J.D., Senior Vice President, General Counsel
- John Oram, M.B.A., Senior Vice President, Program and Portfolio Management
- Robin Wagner, Senior Vice President, Human Resources
- Carl L. Gordon, Ph.D., C.F.A., Board Member
- Jean-Jacques Bienaimé, M.B.A., Lead Independent Director
- Nima Farzan, M.B.A., Board Member
- Mary Ann Gray, Ph.D., Board Member
- Tomer Kariv, J.D., Board Member
- Julius Knowles, M.B.A., Board Member
- Ran Nussbaum, Board Member
- Alpna Seth, Ph.D., Board Member
Last updated: 2024-12-31
Kintara Therapeutics, Inc.
VAL-083, REM-001
Kintara Therapeutics is a clinical stage drug development company focused on developing and commercializing anti-cancer therapies for drug-resistant solid tumors.
About | Leadership | Directors | About | About | About | About | Contact | Careers | About | About | About
Symbol: KTRA
Recent Price: $0.22
Industry: Biotechnology
CEO: Mr. Jeffrey A. Bacha B.Sc., M.B.A.
Sector: Healthcare
Employees: 1
Address: 12707 High Bluff Drive, San Diego, CA 92130
Phone: 858 350 4364
Leadership
- Robert E. Hoffman, President, CEO, CFO and Chairman of the Board
- Greg A. Johnson, (Acting) Head of Operations
- Laura Johnson, Director
- Tamara A. Favorito, Director
- Robert J. Toth, Jr., M.B.A., Director
Last updated: 2024-12-31
Kezar Life Sciences, Inc.
KZR-616
Kezar Life Sciences is a clinical-stage biotechnology company focused on developing novel small molecule therapeutics to address unmet needs in immune-mediated diseases and cancer in the United States.
About | About | About | About | Directors | About | Contact | Contact | Careers | Careers | Careers | Leadership | About | About | About | About | About | About | About | News | About | Careers | Contact | Careers | Careers | Careers | About | About | About | About
Symbol: KZR
Recent Price: $6.82
Industry: Biotechnology
CEO: Dr. Christopher J. Kirk Ph.D.
Sector: Healthcare
Employees: 58
Address: 4000 Shoreline Court, South San Francisco, CA 94080
Phone: 650 822 5600
Leadership
- Christopher Kirk, PhD, Chief Executive Officer, Co-Founder
- Marc Belsky, Chief Financial Officer
- Mark Schiller, Chief Legal Officer
- Neel K. Anand, DPhil, SVP, Research and Drug Discovery
- Zung To, SVP, Clinical Development
- Gitanjali Jain, SVP, Investor Relations and External Affairs
- Michelle Greenman, VP, Global Regulatory Affairs
- Jim Kirchner, PhD, VP, CMC and Supply Chain
- Andrew Basham, VP, Legal Affairs
- Dave Braggs, VP, Quality Assurance
- Pattie Chiang, SVP, Corporate Controller
- Tony Muchamuel, VP, Pharmacology & Toxicology
- Kiruthi Palaniswamy, PharmD, VP, Medical Affairs
- Mary Rogers, VP, Financial Planning & Analysis
- Joe Tedrick, VP, Human Resources
- Jinhai Wang, PhD, VP, Drug Metabolism & Pharmacokinetics
- John Fowler, Co-Founder
- Graham Cooper, Board Member, Beam Therapeutics, Former CFO, Receptos
- Franklin Berger, Founder
- Elizabeth Garner, MD, MPH, Chief Science Officer
- Michael Kauffman, MD, PhD, President, Chief Executive Officer, and Director
- Micki Klearman, MD, Former Group Medical Director
- Courtney Wallace, Venture Partner
Last updated: 2024-12-31
Nkarta, Inc.
NKX101 and NKX019
Nkarta, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing cell therapies for the treatment of cancer. The company specializes in cellular immunotherapy using chimeric antigen receptors on natural killer cells to target tumor antigens.
About | Contact | Careers | Careers | Careers | Jobs | Careers | Careers | Careers | Careers | Careers | Careers | Contact | Careers | About | Careers
Symbol: NKTX
Recent Price: $2.32
Industry: Biotechnology
CEO: Mr. Paul J. Hastings
Sector: Healthcare
Employees: 150
Address: 6000 Shoreline Court, South San Francisco, CA 94080
Phone: 415 582 4923
Last updated: 2024-12-31
Nurix Therapeutics, Inc.
NX-2127, NX-5948, NX-1607, NX-0255
Nurix Therapeutics, Inc. is a biopharmaceutical company that focuses on developing small molecule therapies for cancer and immune disorders, with products targeting BTK and CBL-B proteins. The company collaborates with Gilead Sciences and Sanofi.
Symbol: NRIX
Recent Price: $18.64
Industry: Biotechnology
CEO: Dr. Arthur T. Sands M.D., Ph.D.
Sector: Healthcare
Employees: 284
Address: 1700 Owens Street, San Francisco, CA 94158
Phone: 415 660 5320
Last updated: 2024-12-31
PureTech Health plc
Kar XT
Pure Tech Health plc is a clinical-stage biotherapeutics company focused on the discovery, development, and commercialization of medicines for a range of diseases including inflammatory, fibrotic, immunological, and neurological conditions.
Symbol: PRTC
Recent Price: $18.98
Industry: Biotechnology
CEO: Dr. Bharatt M. Chowrira J.D., Ph.D.
Sector: Healthcare
Employees: 90
Address: 6 Tide Street, Boston, MA 02210
Phone: 617 482 2333
Last updated: 2024-12-31
PTC Therapeutics, Inc.
Translarna, Emflaza, Tegsedi, Waylivra, Evrysdi
PTC Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for patients with rare disorders. The company offers a portfolio of products including treatments for Duchenne muscular dystrophy, rare diseases, and spinal muscular atrophy.
About | History | Leadership | About | Contact | Careers | Careers | Jobs | About | About | About | About
Symbol: PTCT
Recent Price: $45.77
Industry: Biotechnology
CEO: Dr. Matthew B. Klein F.A.C.S., M.D., M.S.
Sector: Healthcare
Employees: 988
Address: 100 Corporate Court, South Plainfield, NJ 07080
Phone: 908 222 7000
Leadership
- Matthew B. Klein, M.D., M.S., F.A.C.S., CEO, PTC Therapeutics, Inc.
- Neil Almstead, Ph.D., Chief Technical Operations Officer
- John Baird, Ph.D., Chief of Staff to the CEO
- Mark E. Boulding, Executive Vice President and Chief Legal Officer
- Lee Golden, M.D., Chief Medical Officer
- Pierre Gravier, Chief Financial Officer
- Mary Frances Harmon, Senior Vice President, Corporate and Patient Relations
- Linda Montella-Carter, Senior Vice President and Chief Information Officer
- Eric Pauwels, Chief Business Officer
- Hege Sollie-Zetlmayer, Chief Human Resources Officer
- Christine Utter, Senior Vice President, Chief Accounting Officer and Head of People Services
- Michael Schmertzler, Chairman
- William F. Bell, Jr., Managing Director and Head of Healthcare Services Practice, L.E.K. Consulting
- Allan Jacobson, Ph.D., University of Massachusetts Chan Medical School
- Stephanie S. Okey, M.S., Former SVP, Head of North America, Rare Disease – Genzyme
- Emma Reeve, Independent Board Director
- Mary Smith, The VENG Group
- David P. Southwell, Former CEO, TScan Therapeutics
- Glenn D. Steele, Jr., M.D., Ph.D., Chairman, GSteele Health Solutions
- Alethia Young, Chief Financial Officer, Bicycle Therapeutics
- Jerome B. Zeldis, M.D., Ph.D., Independent Board Director
Last updated: 2024-12-31
Verve Therapeutics, Inc.
VERVE-101
Verve Therapeutics, Inc. is a genetic medicines company developing gene editing treatments for cardiovascular diseases, primarily through its lead product VERVE-101.
Symbol: VERV
Recent Price: $5.54
Industry: Biotechnology
CEO: Dr. Sekar Kathiresan M.D.
Sector: Healthcare
Employees: 255
Address: 500 Technology Square, Cambridge, MA 02139
Phone: 617 603 0070
Leadership
- Andrew Ashe, President, Chief Operating Officer and General Counsel
- Victoria Bartlett, Vice President, Program and Alliance Management
- Dan Balian, Associate Director, Supply Chain Management
- Allen Barrett, Director, Corporate Counsel
Last updated: 2024-12-31
Viking Therapeutics, Inc.
VK2809
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapies for metabolic and endocrine disorders, with lead drug candidate VK2809 in Phase IIb trials for non-alcoholic steatohepatitis.
Symbol: VKTX
Recent Price: $39.77
Industry: Biotechnology
CEO: Dr. Brian Lian Ph.D.
Sector: Healthcare
Employees: 30
Address: 9920 Pacific Heights Boulevard, San Diego, CA 92121
Phone: 858 704 4660
Leadership
- Lawson Macartney, DVM, Ph.D., Chairman
- Matthew W. Foehr, Chief Executive Officer
- Kathy Rouan, Ph.D.,
- Charles A. Rowland Jr.,
- Matthew Singleton,
- Brian Lian, Ph.D.,
Last updated: 2024-12-31
Xenetic Biosciences, Inc.
XCART
Xenetic Biosciences, Inc. is a biopharmaceutical company that focuses on advancing XCART, a personalized CAR T platform technology for oncology therapeutics and biologic drug development.
About | Leadership | Directors | About | About | About | Contact | Careers | About | About | About
Symbol: XBIO
Recent Price: $4.05
Industry: Biotechnology
CEO: Mr. James F. Parslow
Sector: Healthcare
Employees: 4
Address: 40 Speen Street, Framingham, MA 01701
Phone: 781 778 7720
Leadership
- James F. Parslow, Interim Chief Executive Officer and Chief Financial Officer
- Scott N. Cullison, Business Development
- Reid P. Bissonnette, Ph.D., Translational Research and Development
- Cory C. Kauffman, Ph.D., Chief Technology Officer
- Adam Logal, Chairman
- Grigory G. Borisenko, Ph.D., Non-Executive Director
- James Eric Callaway, Ph.D., Non-Executive Director
- Firdaus Jal Dastoor, FCS, Non-Executive Director
- Dmitry Genkin, MD, Non-Executive Director
- Roger Kornberg, Ph.D., Non-Executive Director
- Moshe Mizrahy, Non-Executive Director
- Dr. Alexey Vinogradov, Non-Executive Director
Last updated: 2024-12-31
XBiotech Inc.
True Human monoclonal antibodies
XBiotech Inc. discovers, develops, and commercializes True Human monoclonal antibodies targeting inflammatory and infectious diseases, with additional development in interleukin-1 alpha therapies for various medical conditions and COVID-19 therapy.
Symbol: XBIT
Recent Price: $4.09
Industry: Biotechnology
CEO: Mr. John Simard
Sector: Healthcare
Employees: 94
Address: 5217 Winnebago Lane, Austin, TX 78744
Phone: 512 386 2900
Last updated: 2024-12-31
Xilio Therapeutics, Inc.
XTX101
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients with a focus on tumor-selective therapies.
Symbol: XLO
Recent Price: $0.97
Industry: Biotechnology
CEO: Dr. Rene Russo BCPS, Pharm.D.
Sector: Healthcare
Employees: 73
Address: 828 Winter Street, Waltham, MA 02451
Phone: 617 430 4680
Last updated: 2024-12-31